EHSI Elite Health Systems Inc.
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1089815 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-348.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-155.6%
Net margin-261.7%
FCF margin—
EBITDA margin—
Returns
ROE-307.3%
ROA-247.2%
ROIC (approx.)-474.7%
Asset turnover0.94x
Leverage & solvency
Liabilities / assets34.4%
Debt / equity0.00x
Current ratio1.37x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.50x
Accruals ratio-122.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.31M | $1.40M | $1.02M | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.14M | $1.28M | — | — | $0 | $0 | — | — |
| Gross profit | $168,000 | $117,000 | — | — | $0 | $0 | — | — |
| SG&A expense | $1.71M | $1.42M | $1.92M | $1.17M | $445,000 | $427,000 | $494,000 | $387,000 |
| Operating income | -$1.54M | -$1.30M | -$1.80M | -$1.17M | -$445,000 | -$427,000 | -$494,000 | -$387,000 |
| Interest expense | — | — | — | — | — | — | — | $0 |
| Pretax income | — | — | -$5.78M | -$1.16M | -$441,000 | -$424,000 | -$1.02M | -$290,000 |
| Income tax | — | — | — | — | — | — | $0 | $0 |
| Net income | -$1.53M | -$1.29M | -$5.78M | -$1.16M | -$441,000 | -$424,000 | -$1.02M | -$290,000 |
| EPS (basic) | -0.05 | -0.05 | — | -0.05 | -0.02 | -0.02 | — | -0.02 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.30M | $2.60M | $3.76M | $3.97M | $3.12M | $3.70M | $4.03M | $3.17M |
| Current assets | $1.83M | $3.27M | $4.48M | $4.27M | $3.16M | $3.73M | $4.25M | $3.19M |
| PP&E, net | $9,000 | $10,000 | $7,000 | $1.04M | $822,000 | $589,000 | $72,000 | $66,000 |
| Goodwill | $984,000 | $984,000 | $984,000 | — | — | — | $0 | — |
| Total assets | $3.92M | $5.43M | $6.66M | $5.31M | $3.98M | $4.32M | $4.32M | $3.80M |
| Current liabilities | $1.34M | $1.36M | $1.34M | $270,000 | $167,000 | $51,000 | $94,000 | $93,000 |
| Total liabilities | $1.35M | $1.37M | $1.35M | $291,000 | $197,000 | $91,000 | $143,000 | $143,000 |
| Shareholders' equity | $2.57M | $4.06M | $5.31M | $5.02M | $3.79M | $4.23M | $4.18M | $3.66M |
| Shares outstanding | 28.52M | 28.52M | 28.52M | 21.94M | 21.41M | 21.41M | 19.98M | 17.38M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.35M | -$1.26M | -$1.49M | -$817,000 | -$334,000 | -$297,000 | -$527,000 | -$72,000 |
| Investing cash flow | $0 | $0 | -$83,000 | -$225,000 | -$241,000 | -$515,000 | $263,000 | $0 |
| Financing cash flow | $53,000 | $100,000 | $1.36M | $1.89M | $0 | $474,000 | $1.12M | $1.05M |
| Stock-based compensation | $41,000 | $41,000 | $65,000 | $504,000 | $0 | $0 | — | — |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.